JPL Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5K Buy
162
+4
+3% +$600 0.01% 388
2026
Q1
$24.2K Buy
+158
New +$24.2K 0.01% 360
2025
Q4
Sell
-91
Closed -$11.7K 786
2025
Q3
$11.7K Buy
+91
New +$11.1K ﹤0.01% 513

Other funds holding NVS

JPL Wealth Management's NVS Position: Q2 2026 in Review

JPL Wealth Management increased its Novartis (NVS) stake by 2.5% in Q2 2026, buying an estimated $600 and bringing the position to 162 shares worth $25.5K. The position accounts for 0.01% of the portfolio, ranked #388.

JPL Wealth Management first reported a position in NVS in Q3 2025 and has held it in 3 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • JPL Wealth Management held 162 shares of Novartis worth $25.5K as of Q2 2026.
  • JPL Wealth Management bought 4 Novartis shares in Q2 2026, an estimated $600.
  • Novartis made up 0.01% of JPL Wealth Management's portfolio in Q2 2026, its #388 holding.
  • JPL Wealth Management first reported a position in Novartis in Q3 2025 and has held it in 3 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.